Somatostatin Receptor Type 2 Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 16
SKU : PH3898
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Somatostatin Receptor Type 2 Market?
Somatostatin Receptor Type 2 Market is expected to grow at a high CAGR of during the forecast period 2023-2030.
Who are the key players in Somatostatin Receptor Type 2 Market?
Major players are Amryt Pharma plc, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Ipsen SA, Progenics Pharmaceuticals Inc, Strongbridge Biopharma plc and Zucara Therapeutics Inc.
Related Reports
pharmaceuticalsAngiotensin II Receptor Blockers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350
pharmaceuticalsToll Like Receptor 3 Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 28
Starting from
$4350
pharmaceuticalsMetastatic Prostate Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 28
Starting from
$4350
information-communication-and-technologyElectrostatic Precipitator Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 November 30
Starting from
$4350
clinical-diagnosticsCryostat Microtome Equipment Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 18
Starting from
$4350
energy-and-powerSubstation Automation Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 14
Starting from
$4350